Liwen Wu
Directeur/Membre du Conseil chez Shanghai Genomics, Inc.
Provenance du réseau au premier degré de Liwen Wu
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Peking Union Medical College
2
| College/University | Other Consumer Services | 2 |
Peking Union Medical College Hospital
 Peking Union Medical College Hospital Other Consumer ServicesConsumer Services Peking Union Medical College Hospital is a clinical college of Peking Union Medical College in Beijing, CN. It is also a clinical medical research institute of the Chinese Academy of Medical Sciences and one of the national centers for the diagnosis and treatment of difficult and complicated diseases designated by the Ministry of Health. The hospital is well-known for its comprehensive advantages in multiple disciplines, with a complete range of disciplines, strong technical strength, and comprehensive development in medical, teaching, research, and management.
1
| Private Company | Other Consumer Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Liwen Wu via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| GNI GROUP LTD. | Biotechnology | Founder Director/Board Member Chief Operating Officer | |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GNI-EPS Pharmaceuticals, inc. | Chief Executive Officer Director/Board Member | ||
Berkeley Advanced Biomaterials, Inc.
 Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Berkeley Advanced Biomaterials, Inc. manufactures and distributes calcium-based products. Its products include HAP/TCP, nanocrystals, powder, granules and blocks. The company was incorporated by François Génin in October 1996 and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Biotechnology | President Director of Finance/CFO | |
| Shandong University | College/University | Undergraduate Degree | |
| Kai Wo Asset Management Ltd. | Director/Board Member | ||
National Association of Corporate Directors
 National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The National Association of Corporate Directors is a non-profit organization that provides essential resources to help directors strengthen board leadership. The American company was founded by Maryann Bruce and the CEO is Peter R. Gleason. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Keio University | College/University | Graduate Degree | |
| Portland State University | College/University | Doctorate Degree | |
| BEIJING AEROSPACE CHANGFENG CO.,LTD | Medical Specialties | Director/Board Member | |
| Peking University School of Pharmaceutical Sciences | College/University | Corporate Officer/Principal | |
| NEW HORIZON HEALTH LIMITED | Medical/Nursing Services | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree | |
Fitch Group, Inc.
 Fitch Group, Inc. Packaged SoftwareTechnology Services Fitch Group, Inc. engages in the provision of credit ratings, opinions, research, and financial data for credit markets. It offers debt market solutions, corporate strategy and business planning, and custom research. The company was founded on December 13, 2005 and is headquartered in New York, NY. | Packaged Software | Corporate Officer/Principal | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal | |
| Jonsson Comprehensive Cancer Center | Corporate Officer/Principal | ||
| The Institute for Molecular Medicine | Director/Board Member | ||
| SOFTBANK CORP. | Wireless Telecommunications | Public Communications Contact | |
| Beijing Pharmaceutical Association | Corporate Officer/Principal | ||
Duff & Phelps Credit Rating Co.
 Duff & Phelps Credit Rating Co. Investment ManagersFinance Duff & Phelps Credit Rating Co. issues credit ratings on corporate bonds, preferred stocks, commercial paper, and CDs. The company is headquartered in Chicago, IL. | Investment Managers | Corporate Officer/Principal | |
| Thunderbird School of Global Management | College/University | Graduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree | |
| Beijing Medical University | College/University | Undergraduate Degree | |
| Chinese National Genome Center | Corporate Officer/Principal | ||
| Chinese Pharmacopoeia Commission | Corporate Officer/Principal | ||
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Pharmaceuticals: Major | Director/Board Member | |
| Chinese Practicing Pharmacist Association | Chairman | ||
| Chinese Pharmaceutical Association | Director/Board Member | ||
| SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Director/Board Member | |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT. | College/University | Doctorate Degree | |
| Cullgen Shanghai, Inc. | Chairman | ||
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Chairman | |
| Shanghai Jiao Tong University | College/University | Corporate Officer/Principal | |
| European Molecular Biology Organization | Corporate Officer/Principal |
Statistiques
Internationale
| Chine | 18 |
| Etats-Unis | 16 |
| Japon | 4 |
| Hong Kong | 4 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Health Services | 2 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 26 |
| Corporate Officer/Principal | 15 |
| Chairman | 12 |
| Independent Dir/Board Member | 6 |
| Undergraduate Degree | 5 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ying Luo | 17 |
| Thomas Eastling | 17 |
| Da Kui Li | 9 |
| Hong Wu | 8 |
| Hitoshi Matsuda | 6 |
| Yanping Ye | 3 |
| Ru Tai Hui | 3 |
